The Mexico City Policy is

The Mexico City Policy is also flawed on evidentiary and public health grounds. A 2011 study found that enforcement of the Mexico City Policy by the George W Bush administration led to an increase in abortion rates in sub-Saharan Africa, probably because of decreased contraception access and increased unwanted pregnancies. The resurrection of the Mexico City Policy by the Donald J Trump administration looks set to yield similar or worse outcomes in the years ahead, in settings served by NGOs and agencies that rely on US federal funding. For example, , a family planning NGO, currently receives USAID funding exclusively for voluntary contraception services. The conditions of the would restrict MSI from providing abortion services using other funding, in countries where abortion is permitted. If MSI were to continue providing abortion services anywhere, the organisation would have to forfeit USAID funding for contraception services. This could have major implications in setting such as Bolivia, which is experiencing a Zika virus epidemic. In light of South American governments issuing unprecedented warnings urging women to avoid pregnancy, Bolivian women are likely to seek contraception services. In 2015 alone, 98 000 Bolivian women accessed contraception services offered by MSI, resulting in 33 000 unwanted pregnancies being averted. MSI has disavowed Trump\'s Mexico City Policy and stands to lose its USAID support.
Significant progress has been made in reducing maternal and neonatal mortality in the past 15 years, but additional improvements will require a comprehensive approach that targets all causes of maternal and newborn mortality. Further A-443654 of maternal and newborn deaths is a priority for achieving the Sustainable Development Goals and for implementing the UN Global Strategy for Women\'s, Children\'s and Adolescents\' Health, and is also critical for two strategic plans—Every Newborn: An Action Plan to End Preventable Deaths (ENAP) and the Strategies toward Ending Preventable Maternal Mortality (EPMM). As part of this comprehensive approach, inheritance of acquired characteristics is impossible to neglect the importance of infection as an underlying and contributing cause of maternal and newborn mortality. Deaths due to infection occur mainly through sepsis—a potentially life-threatening condition caused by a dysregulated host response to infection and organ dysfunction. Infections cause about 11% of maternal deaths, and are also a significant contributor to many deaths attributed to other conditions. The risk of early neonatal sepsis increases in the event of maternal infection. Early neonatal sepsis causes about 8% of all neonatal deaths, but the proportion of late neonatal deaths due to sepsis is four times higher. Deaths from maternal and neonatal sepsis expose broader health determinants and underlying issues of quality of care including infrastructure constraints, inconsistent use of preventive measures, delayed diagnosis, and poor management of infection and its complications. Considering the importance of effective prevention, identification, and management of maternal and neonatal sepsis in reducing maternal and newborn deaths, WHO and Jhpiego have launched the Global Maternal and Neonatal Sepsis Initiative. This initiative consists of a broad programme of work that will be delivered through a collaborative and innovative approach combining research, innovation, service delivery programming, and advocacy. Working at the global, national, and health-care facility levels, the Initiative will identify strategic opportunities to increase and strengthen the response to maternal and newborn sepsis. The summarises the Initiative\'s vision, goals, priority areas of work, and objectives. The Initiative has received extensive support from the International Federation of Gynecology and Obstetrics, the International Confederation of Midwives, the International Pediatric Association, the Global Sepsis Alliance, and the Surviving Sepsis Campaign, in collaboration with the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.